News

C&EN4d
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor | ACS Pharmacology & Translational Science
In 2018, the United States Food and Drug Administration (FDA) approved Aimovig (erenumab) for the prevention of migraine. Erenumab is the first FDA approved antibody therapeutic against a ...
ahajournals.org4d
G-Protein–Coupled Receptors in Heart Disease | Circulation Research - AHA/ASA Journals
Functional roles of GPCRs (G-protein–coupled receptors) ... Zhai P, Yamamoto M, Galeotti Jet al. Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes ...